Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
ASAIO Transactions|July 1, 1989
Long-term clinical experience with HELP-LDL-apheresis in combination with HMG-CoA-reductase inhibitors for maximum treatment of coronary heart disease associated with severe hypercholesterolemiaT Eisenhauer, V W Armstrong, P Schuff-Werner, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 16, 1975
Fluoride determination in plasma by ion selective electrodes: a simplified method for the clinical laboratoryC Fuchs, D Dorn, C A Fuchs, et al.
Deutsche Medizinische Wochenschrift (1946)|July 8, 1983
[Muscular carnitine-palmityl-transferase deficiency]K W Rumpf, H Kaiser, H H Goebel, et al.
Nephron|January 1, 1977
Effect of dialysate calcium concentration on plasma parathyroid hormone during hemodialysisC H McIntosh, C Fuchs, D Dorn, et al.
Klinische Wochenschrift|July 3, 1989
[Absence of nocturnal decrease in blood pressure in 24-hour blood pressure monitoring: an indication of secondary hypertension]I Schrader, C Person, U Pfertner, et al.
Kidney International|April 1, 1988
Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltrationJ Schrader, W Stibbe, V W Armstrong, et al.
Deutsche Medizinische Wochenschrift (1946)|May 18, 1979
[Acute renal failure in alcoholic myopathy (author's transl)]K W Rumpf, H Kaiser, D Matthaei, et al.
Zeitschrift Fur Kardiologie|December 1, 1989
[24-hour blood pressure behavior in patients with untreated and treated hypertension in comparison with normotensive patients]J Schrader, S Schuster, G Schoel, et al.
Artificial Organs|May 1, 1978
Clinical experience with continuously monitored fluid balance in automatic hemofiltrationP Kramer, W Wigger, D Matthaei, et al.
Lancet (London, England)|December 21, 1985
Association of ethylene-oxide-induced IgE antibodies with symptoms in dialysis patientsK W Rumpf, S Seubert, A Seubert, et al.
Pageof 13